Literature DB >> 20820908

Cytotoxic activity of the titanium alkoxide (OPy)(2)Ti(4AP)(2) against cancer colony forming cells.

Elizabeth A Williamson1, Timothy J Boyle, Rebecca Raymond, Jacqueline Farrington, Claire Verschraegen, Montaser Shaheen, Robert Hromas.   

Abstract

A novel family of titanium alkoxides with two stable pyridinemethoxide moieties bound to a titanium metal center were synthesized and tested for cytotoxic activity on a variety of cancer cell lines using colony formation assays. One compound, (OPy)(2)Ti(4AP)(2), where OPy is NC(5)H(5)CH(2)O(-), and 4AP is 4-aminophenoxide ((-)OC(6)H(5)(NH(2))-4), demonstrated increased cytotoxicity in breast, colon, and pancreatic cancer cell lines at 100 nanomolar levels with only short exposures. Further, (OPy)(2)Ti(4AP)(2) had activity in colon and pancreatic cancer cell lines that are usually resistant to chemotherapy. This demonstrates that these titanium compounds may have a role in anti-cancer therapy, similar to platinum-based compounds, and the (OPy)(2)Ti(4AP)(2) compound specifically deserves further investigation as an anti-cancer agent in chemo-resistant solid tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20820908      PMCID: PMC3977178          DOI: 10.1007/s10637-010-9530-3

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  23 in total

1.  Synthesis, Structure and Biological Activity of Amide-Functionalized Titanocenyls: Improving their Cytotoxic Properties.

Authors:  Li Ming Gao; Jaime Matta; Arnold L Rheingold; Enrique Meléndez
Journal:  J Organomet Chem       Date:  2009-12-15       Impact factor: 2.369

2.  The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair.

Authors:  Suk-Hee Lee; Masahiko Oshige; Stephen T Durant; Kanwaldeep Kaur Rasila; Elizabeth A Williamson; Heather Ramsey; Lori Kwan; Jac A Nickoloff; Robert Hromas
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-06       Impact factor: 11.205

Review 3.  Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.

Authors:  D Lebwohl; R Canetta
Journal:  Eur J Cancer       Date:  1998-09       Impact factor: 9.162

4.  Redox potentials of Ti(IV) and Fe(III) complexes provide insights into titanium biodistribution mechanisms.

Authors:  Claire J Parker Siburt; Emily M Lin; Sara J Brandt; Arthur D Tinoco; Ann M Valentine; Alvin L Crumbliss
Journal:  J Inorg Biochem       Date:  2010-04-18       Impact factor: 4.155

5.  Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.

Authors:  J A Plumb; G Strathdee; J Sludden; S B Kaye; R Brown
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

6.  Controlled synthesis of a structurally characterized family of sterically constrained heterocyclic alkoxy-modified titanium alkoxides.

Authors:  Timothy J Boyle; Robin M Sewell; Leigh Anna M Ottley; Harry D Pratt; Christopher J Quintana; Scott D Bunge
Journal:  Inorg Chem       Date:  2007-03-05       Impact factor: 5.165

7.  Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer.

Authors:  C V Christodoulou; D R Ferry; D W Fyfe; A Young; J Doran; T M Sheehan; A Eliopoulos; K Hale; J Baumgart; G Sass; D J Kerr
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

Review 8.  Particular aspects of platinum compounds used at present in cancer treatment.

Authors:  Bernard Desoize; Claudie Madoulet
Journal:  Crit Rev Oncol Hematol       Date:  2002-06       Impact factor: 6.312

9.  Inclusion complexes of the antitumour metallocenes Cp(2)MCl(2) (M = Mo, Ti) with cucurbit[n]urils.

Authors:  Damian P Buck; P Manohari Abeysinghe; Carleen Cullinane; Anthony I Day; J Grant Collins; Margaret M Harding
Journal:  Dalton Trans       Date:  2008-03-14       Impact factor: 4.390

10.  Anti-proliferative activity and mechanism of action of titanocene dichloride.

Authors:  C V Christodoulou; A G Eliopoulos; L S Young; L Hodgkins; D R Ferry; D J Kerr
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more
  1 in total

1.  Synthesis, spectral characterization, and antiproliferative studies of mixed ligand titanium complexes of adamantylamine.

Authors:  Raj Kaushal; Nitesh Kumar; Ashun Chaudhary; Saroj Arora; Pamita Awasthi
Journal:  Bioinorg Chem Appl       Date:  2014-02-27       Impact factor: 7.778

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.